Ludwig Enterprises, Inc. Stock

Equities

LUDG

US54973P4019

Market Closed - OTC Markets Other stock markets 03:26:56 2024-05-02 pm EDT			5-day change	1st Jan Change
0.27 ^USD	-6.90%		+35.00%	+99.26%

Apr. 16	Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 19	Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	CI

Financials (USD)

Sales 2022	-	Sales 2023	-	Capitalization	21.07M
Net income 2022	-	Net income 2023	-2M	EV / Sales 2022	-
Net Debt 2022	819K	Net Debt 2023	1.26M	EV / Sales 2023	-
P/E ratio 2022	-89.4 x	P/E ratio 2023	-15.8 x	Employees	3
Yield 2022 *	-	Yield 2023	-	Free-Float	0%

More Fundamentals * Assessed data

Chart Ludwig Enterprises, Inc.

Duration

Period

Style

Dynamic Chart

Latest news about Ludwig Enterprises, Inc.

Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	Mar. 19	CI
Ludwig Enterprises Inc. Announces Patent Filing for Breakthrough in Identifying Mrna Genes Associated with Certain Cancers	Mar. 06	CI
Ludwig Enterprises, Inc. announced that it has received $0.04 million in funding	Feb. 11	CI
Ludus Enterprises, Inc. Receives Continuing Review Approval on Planned Clinical Study from Advarra IRB, Columbia, MD	Jan. 31	CI
Ludwig Enterprises, Inc. Announces Executive Changes	Dec. 01	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Ludwig Enterprises, Inc. Appoints Scott Silverman as Chief Financial Officer	Nov. 16	CI
Ludwig Enterprises, Inc. Announces Marvin S. Hausman as Chief Executive Officer	23-09-19	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-21	CI
Ludwig Enterprises Announces Launches of New Nutraceutical and Strategic Marketing Plan	23-04-25	CI
Ludwig Enterprises Launches Nugenea, Groundbreaking Nutraceutical to Fight Inflammation	23-04-12	CI
Ludwig Enterprises, Inc. Auditor Raises 'Going Concern' Doubt	23-02-14	CI
Ludwig Enterprises, Inc. Receives Institutional Review Board Approval on Bladder Cancer Study	23-01-03	CI

More news

Press releases Ludwig Enterprises, Inc.

Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024	Mar. 19	AQ
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers	Mar. 06	AQ
Precision Genomics (a Ludwig Company) Will Break Major Medical News at a Presentation for LD Micro Tuesday, Oct. 25th, 2022	22-10-24	NE
Ludwig Enterprises : Hires Anne Blackstone, CRNA as CEO and Director	22-07-12	PU
Ludwig Enterprises : Sucessful 1st Round Funding -- New CEO -- New Division	22-07-05	PU